NCT01915771View on ClinicalTrials.gov

Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 29, 2013

Primary Completion Date

August 23, 2013

Study Completion Date

August 23, 2013

Conditions
Intra-subject Variability of Pharmacokinetics
Interventions
DRUG

lomitapide

20 mg dose

Trial Locations (1)

CR7 7YE

Richmond Pharmacology, Croydon

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT01915771 - Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects | Biotech Hunter | Biotech Hunter